Search Results

167 search results found

Past Deadline: Apr 6, 2021

Startup Speakers for Work of the Future @MIT Webinar 4/29 and 5/4

speaker

MIT Startup Exchange is looking for 3-4 startup speakers to participate in a pre-recorded webcast on April 29 and a possible follow-up live event on May 4, both focused on work of the future.
Past Deadline: Apr 12, 2021

Japanese multinational company seeking startups for collaboration within the field of energy storage and related battery systems

partnership

Japanese multinational company looking globally for startups to collaborate with in the field of energy storage and related battery systems.
Past Deadline: Jan 10, 2025

Apply for the 2025 Sloan Healthcare Innovation Prize

speaker

Apply for the 2025 Sloan Healthcare Innovation Prize. Do you have an innovative solution to a problem in healthcare or biotech? We are now accepting applications to the Sloan Healthcare Innovation Prize Competition.
AgTech Workshop 2018 - Open Innovation and Investment

September 26, 2018 | Startup Exchange Video | Duration: 19:47

Alan Kriz - Open Innovation and Investment
February 28 - 29, 2024 | Conference

2024 MIT AI Conference: Tech, Business, and Ethics - Startup Exchange Lightning Talks

Boston Marriott Cambridge

The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Interpretable AI

March 18, 2019 | Startup Exchange Video | Duration: 18:56

Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
Stratagen Bio

Cambridge, MA

Biotechnology

Tumor hypoxia is characterized by extremely low levels of oxygen (<15.2 mmHg/2% O2). It occurs in fifty percent1 of all tumors and is a well-established negative prognostic indicator. Poor outcomes are seen in patients with hypoxic tumors in cancers including breast, cervical, head and neck, soft... More

Keywords:

Oxygen Sensing, Magnetic Resonance Imaging, Image-Guided Therapies, personalized medicine
PathAI

Boston, MA

Biotechnology

The mission at PathAI is to transform, accelerate and improve cancer diagnosis and cancer care by integrating pathology machine learning / artificial intelligence (AI) with traditional pathology methods in both research and clinical labs. By leveraging recent advances in computational processing... More
Kytopen Corporation

Cambridge, MA

Biotechnology

Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More

Keywords:

Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells
Sports, Nutrition & Wellness - Panel Discussion

June 22, 2017 | Startup Exchange Video | Duration: 43:41
Panel Discussion

How can technology improve the lifestyle choices we make and how productive we are at work over time?

As wearables move from measuring physical data to measuring brain health, how can we “listen” to our bodies to minimize stress, and avoid lost productivity?

What nutritional technologies will enable individuals and companies to make the right dietary decisions for healthier and happier lives?

What role do companies play in furthering these changes?

Panelists:

Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health

Matthew Decker, Global Technical Leader - Comfort and Biophysics Group, W.L. Gore & Associates

David T. Thibodeau, Managing Director, Wellvest Capital

Josh Sarmir, Co-Founder & CEO, SplitSage

Moderator: Trond Undheim, Ph.D., Lead, MIT Startup Exchange, MIT ILP

Search Results

Filter Results